How to Help Your Patients Save Money on Xigduo XR: A Provider's Guide to Savings Programs

Medication cost is one of the most common reasons patients with type 2 diabetes don't fill or don't adhere to their prescriptions. Xigduo XR (dapagliflozin/metformin extended-release) can cost over $574 per 30-day supply at retail without insurance — a significant barrier for many patients, particularly those on Medicare or with limited incomes.

This guide provides clinicians with a practical framework for addressing Xigduo XR cost barriers, connecting patients with the right savings resources, and making prescribing decisions that optimize both clinical outcomes and patient affordability.

Understanding the Cost Landscape for Xigduo XR in 2026

Before directing patients to a savings program, it's helpful to understand the pricing tiers they may be facing:

Brand Xigduo XR (cash price): ~$574-$594 per 30 tablets at retail

Generic dapagliflozin/metformin ER (with GoodRx coupon): ~$168-$290 at select pharmacies

With AstraZeneca Savings Card (commercially insured): As low as $0/month (max $175/fill)

AZ&Me Patient Assistance: Potentially free or very low cost for eligible uninsured/underinsured patients

Medicare patients: Brand often not covered; generic gaining coverage; manufacturer copay cards prohibited

Option 1: Prescribe Generic Dapagliflozin/Metformin ER

The single most impactful step for most patients is switching from brand Xigduo XR to the generic dapagliflozin/metformin hydrochloride extended-release, FDA-approved in early 2026 from manufacturers including Aurobindo and Lupin. These generics are bioequivalent and offer potential savings of 60-70% compared to brand retail price.

Prescribing tips for generics:

Write prescription as "dapagliflozin/metformin HCl extended-release [strength]" with DAW=0 (substitution permitted)

Note: some pharmacies may take 1-2 weeks to fully stock all generic strengths — allow flexibility

Counsel patients that generic appearance (tablet color, shape) may differ from brand — this is expected and does not affect efficacy

Option 2: Prescribe Components Separately

For patients who face high costs even with generics, prescribing dapagliflozin and metformin XR as two separate prescriptions may be the most affordable option:

Generic metformin XR: Often $4-$10 per month at many pharmacies; widely stocked everywhere

Generic dapagliflozin: Available since 2025; less expensive than the combination tablet at some pharmacies with discount coupons

This approach is especially helpful for Medicare patients who can't use manufacturer copay cards, as it separates the medications and allows each to be evaluated for coverage on its own formulary tier.

Option 3: AstraZeneca Savings Card — For Commercially Insured Patients

as little as $0 per 30-day supply with a maximum savings of $175 per fill.

How to help your patients access this:

Direct patients to the Xigduo XR manufacturer website or have your office staff print the savings card at the point of prescribing

Note: the card reduces the patient's copay amount. If your insurance doesn't cover Xigduo XR at all, the card may not apply — in that case, the AZ&Me program is the better option

The separately-offered cash discount (up to $150/fill) applies to patients without insurance coverage for this medication

Option 4: AZ&Me Patient Assistance Program — For Uninsured/Underinsured Patients

AstraZeneca's AZ&Me program offers Xigduo XR at no or reduced cost for patients who meet income eligibility criteria. This includes uninsured, underinsured, and some Medicare patients.

Program details:

Phone: 1-800-292-6363

Requires proof of income and residency; eligibility determined case by case

Medicare patients who qualify for Limited Income Subsidy (LIS) are excluded from the AZ&Me program (they receive government assistance instead)

Processing typically takes 2-4 weeks; bridge supply or bridge prescription may be needed while the application is processed

Option 5: Prescription Discount Cards (GoodRx, SingleCare)

Prescription discount programs like GoodRx and SingleCare are available to all patients regardless of insurance status. They work independently of insurance — patients present the coupon at the pharmacy instead of using their insurance card.

With a GoodRx coupon, generic dapagliflozin/metformin ER can be obtained for around $168 per month at some pharmacies — a 71% discount from average retail. Prices vary by pharmacy and change over time.

Practical note for providers: GoodRx pricing and insurance pricing cannot be stacked. If a patient has insurance, compare the GoodRx coupon price to their copay — whichever is lower should be used.

Optimizing Prior Authorization for Cost-Related Access

If your patient's insurance covers brand Xigduo XR but requires prior authorization, submitting a thorough PA at prescribing time can prevent cost-related gaps in therapy. Key elements for a strong PA:

Document medical necessity for dapagliflozin component (cardiovascular risk, HF, CKD) if applicable — non-glycemic indications often have stronger coverage

Document any prior step therapy medications tried (Synjardy, metformin alone)

If step therapy is required, consider whether patient can trial Synjardy briefly to satisfy step requirements before returning to dapagliflozin-containing therapy

Quick-Reference Summary for Your Team

Commercially insured, high copay: → AstraZeneca Savings Card ($0-$175 max savings)

Uninsured or underinsured: → AZ&Me Program (1-800-292-6363)

Medicare without low-income subsidy: → Generic with GoodRx, or prescribe components separately

Any patient: → Generic dapagliflozin/metformin ER (DAW=0) is the most broadly accessible cost-reduction option

For finding pharmacy availability to pass along to patients, direct them to medfinder — a service that calls pharmacies to check which ones have their medication in stock and texts patients the results.

Also see: How to help your patients find Xigduo XR in stock: A provider's guide.